Prosecution Insights
Last updated: October 27, 2026

Rebecca Lynn Scotland, USPTO Patent Examiner

Listed by the USPTO as SCOTLAND, REBECCA LYNN

Tech Center 1600 • Art Units: 1615 1624 1626 1655

This examiner grants 0% of resolved cases

Analysis

SCOTLAND, REBECCA LYNN is assigned to Tech Center 1600 and Art Unit 1615. Across 16 resolved cases, the allowance rate is 0.0%, the interview lift is 0.0%, and the median time to allowance is 1036 days. The small record limits the predictive value of the figures, while the reported outcomes show no allowances in the resolved cases represented.

The principal companies are L’Oréal, The Procter & Gamble Company, and University of Massachusetts. The leading firms are Bridgeway IP Law Group, PLLC, BIRCH STEWART KOLASCH & BIRCH, LLP, and Entralta. Practitioners should emphasize application-specific claim strategy and a complete response to each ground of rejection.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

0.0%
Allow Rate
-60.0% vs TC avg
94
Total Applications
+0.0%
Interview Lift
1036
Avg Prosecution Days
Based on 16 resolved cases, 2023–2026

Rejection Statute Breakdown

2.9%
§101 Eligibility
9.8%
§102 Novelty
44.9%
§103 Obviousness
30.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18911389 ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID Non-Final OA The Procter & Gamble Company
18298435 Personal Care Composition Containing a Biosurfactant Final Rejection The Procter & Gamble Company
18179486 HAIR CONDITIONING COMPOSITION Final Rejection The Procter & Gamble Company
18849836 COPOLYMER, MEDICAL COMPOSITION, COATED MEDICAL DEVICE, AND METHODS RESPECTIVELY FOR PRODUCING THOSE Non-Final OA TORAY Industries, Inc.
18840745 COMPLEX COACERVATES OF LACTOFERRIN AND OSTEOPONTIN Final Rejection SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
18004937 MICROBIAL INOCULANT FORMULATIONS Final Rejection NewLeaf Symbiotics, Inc.
17922522 METHODS AND SYSTEMS FOR ENHANCING DELIVERY OF THERAPEUTIC AGENTS TO BIOFILMS USING LOW BOILING POINT PHASE CHANGE CONTRAST AGENTS Final Rejection The Regents of the University of Colorado
18276596 ECO-FRIENDLY CAPSULE MANUFACTURING METHOD FOR STABLE LOADING OF ANTISEPTIC DISINFECTANT AND ECO-FRIENDLY CAPSULE MANUFACTURED THEREFROM Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18833119 AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING A BRANCHED ALKANE, A FATTY SUBSTANCE AND A PROPELLANT Non-Final OA L'OREAL
18626302 COMPOSITIONS AND METHODS FOR ALTERING THE COLOR OF HAIR Final Rejection L'Oreal
18114639 ANHYDROUS COSMETIC COMPOSITION INCLUDING OIL AND PLATY MINERAL, AND METHODS OF USE Final Rejection L'OREAL
18262942 COMPOSITION FOR EXTERNAL APPLICATION Non-Final OA KAO CORPORATION
17872477 METHODS AND EQUIPMENT FOR USING CARBON DIOXIDE IN POULTRY EGG INCUBATION TO IMPROVE CHARACTERISTICS OF POULTRY Non-Final OA PRAXAIR TECHNOLOGY, INC.
18260117 NATURAL OIL-BASED PETROLATUM AND METHOD OF MAKING SAME Non-Final OA CARGILL, INCORPORATED
18592423 METHOD OF TREATING INFLAMMATION AND PHOTORECEPTOR CELL DEGENERATION IN RETINAL DEGENERATION PATIENTS Final Rejection The Hong Kong Polytechnic University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Rebecca Lynn Scotland's allowance rate?

0.0% of resolved applications examined by Rebecca Lynn Scotland were allowed (16 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.

Does an interview help with examiner Rebecca Lynn Scotland?

This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Rebecca Lynn Scotland take to allow a patent?

Applications allowed by Rebecca Lynn Scotland took 1,036 days on average from filing to allowance.

Which art unit does examiner Rebecca Lynn Scotland work in?

Rebecca Lynn Scotland examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month